hem.jpg
Cicero Fonder
2008-11-19

Cicero Fonder is a small independent fund manager based in Stockholm, Sweden. Our business idea is to provide a personal, independent, performance-oriented portfolio management with focus on client’s interest and trust.

Cicero Fonder was formed in 2000 by Bengt Holmström and Christer Sterndahlen. Bengt Holmström was formerly CEO at “den Norske Bank” in Stockholm, Trygg Hansa, Trygg Fri Placering, Gota Trygg Fonder. Bengt Holmström launched one of the most successful funds in Sweden, Optionsrättsfonden, at TryggHansa in the early 1990-ties. Christer Sterndahlen was formerly equity strategist at UBS Warburg, Hägglöf & Ponsbach Fondkommission, Gota Bank and the Riksbank . Christer Sterndahlen has been #1 rated as Nordic sector analyst in two rankings, Affärsvärden and Finanstidningen.

Mikael Sandström joined the team in 2003. He was formerly working as institutional sales at Nordea, Swedbank, Gota Bank and Sundsvallsbanken.

Why Cicero Fonder?

Client focused - You as a client are very important to us. You will get direct contact with professional portfolio managers and research analysts.

Niches - We are focused on niches-oriented funds on the Nordic market. In addition, we are managing a BioHealth, Time and a fund-of-fond called Cicero World Wide.

Independent and flexibility - As a small company, there is no bureaucracy in the company. Therefore, we can act without time delays in all market situations.

Cicero Fonder is owned by employees. We are one of the few independent companies in this business.

Experience and analysis - The founders of the company have more than 70 years experiences of the financial market.

We follow the developments on the global financial markets. We have access to all newsflows and analysis from news agencies and investment banks all over the world.

On top of that, we do our own analysis based on an own-designed, well proven model.

Performance-based fees - Our business philosophy is mainly based on performance-based fees.

Company registration number 556 588 – 8731

Authorised by Finansinspektionen 2000-10-24

Reauthorised by Finansinspektionen 2005-05-13

Share capital minimum of Euro 125,000

Custodian: Swedbank Custody SE-105 34 Stockholm

SEB Custody (Cicero Focus)

 

The Board of Directors:

Christer Sterndahlen, Chairman of Cicero Fonder AB, Head of Asset Management

Lars-Gunnar Karlerö, Lawyer, KLA Advokatbyrå

Anders Andersson, PhD Stockholm School of Economics

Jan Sööder, Consulting

Kristina Hårdänge, Consulting

Managing directors:

Håkan Wilnerson, CEO

Bengt Holmström, Asset Management and Marketing

Christer Sterndahlen, Head of Asset Management

Mikael Sandström, Asset Management and Marketing  

Advisors:

Stefan Wikholm, Advisor Cicero BioHealth

Auditors:

Cicero Fonders auditor is Jan Palmqvist, Authorised Public Accountant, Deloitte & Touche, Rehnsgatan 11, 113 79 Stockholm.

Internal Auditors:

Agneta Bremander, Moneo AB.

Compliance:

Kjellander & Ramel AB.

Owners:

Cicero Holding AB 100%

Owners exceeding 10% of the shares in Cicero Holding AB: Christer Sterndahlen, Bengt Holmström and Mikael Sandström

 

 

DISCLAIMER

Cicero Focus, Cicero MÖ Sverige, Cicero TIME, Cicero Global and Cicero Peab-fonden which are under management by Cicero Fonder AB are so called special funds governed by the Swedish Investment Funds Act (2004:46). Thus funds can only be marketed in Sweden. Cicero Sverige, Cicero Biotech & Healthcare, Cicero Avkastning and Cicero World Wide, Cicero World 0-50 and Cicero World Asset Selection are, however, ucits funds, which can be marketed outside Sweden.

There are no guarantees that an investment in Cicero Fonder will not result in a loss. Historical return is no guarantee of future return.

Cicero Fonder AB has no responsibility for determining that an investment from other country than Sweden is being made in accordance with the law of such country.

Any dispute, controversy or claim arising out of or in connection with information regarding Cicero Fonder's all Funds shall be settled in accordance with Swedish law exclusively by Swedish courts.

 

Buy funds

Please contact us if you would like to buy our funds.

Read more about our funds, in swedish

Performance

Quotes


Show all funds

Avkastning - World Wide

Period Fonden
2011-02-08 till 2012-02-08 -5.5%

Visa utveckling mellan datum:


...eller visa för period

2012 07/02 Utv. Sedan 31/12 NAV-kurs
Avkastning -0,0% 0,6% 102,9770
BioHealth -0,7% 4,2% 73,7581
Focus -0,6% 4,0% 101,4300
Global -0,5% 6,7% 74,5430
MÖ Sverige -2,1% 15,4% 88,1355
SRI Sverige -0,8% 8,2% 106,8972
TIME -0,8% 8,0% 51,0165
World Wide -0,6% 4,3% 152,9769
Asset Selection -0,5% 3,7% 92,5125
Peab-fonden -0,8% 9,0% 105,2000
World 0-50 -0,2% 1,4% 101,3679